Allergy EAACI

This study investigates the longitudinal effects of #dupilumab on the nasal passage and gastrointestinal microbiota in patients with diffuse type 2 chronic rhinosinusitis with nasal polyps (#CRSwNP). CRSwNP patients show altered nasal microbiota composition compared to healthy individuals. Dupilumab treatment is associated with a shift of nasal microbiota in CRSwNP, with increasing beneficial genera (Lawsonella, Corynebacterium, and Dolosigranulum). Gastrointestinal microbiota remains unchanged during dupilumab treatment.

✨One of the most liked articles in the social media of Allergy published in 2025:

Dupilumab Treatment Is Associated With Clinical Improvement and a Shift Toward a Health-Associated Nasal Passage Microbiota in Diffuse Type 2 Chronic #Rhinosinusitis. 👉 doi.org/10.1111/all.16600

#Allergy_journal

29.10.2025 10:19 — 👍 0    🔁 0    💬 0    📌 0

I’m so excited to share that my paper on the role of itaconate in allergic airway disease and asthma has just been published in @allergy-eaaci.bsky.social!

You can read the paper here: onlinelibrary.wiley.com/doi/10.1111/...

#itaconate #allergy #asthma #immunometabolism #innateimmunity

25.10.2025 08:13 — 👍 7    🔁 3    💬 1    📌 2

EAACI Position Paper

✨One of the most liked articles in the social media of Allergy published in 2025:

Free Access: The Bronchodilator and Anti-Inflammatory Effect of Long-Acting Muscarinic Antagonists in #Asthma: An EAACI Position Paper. Corresponding author: Ibon Eguíluz-Gracia 👉 doi.org/10.1111/all.16436

23.10.2025 09:00 — 👍 0    🔁 0    💬 0    📌 0

Chronic Spontaneous Urticaria

✨One of the most appreciated/liked articles in the social media of #Allergy published in 2025:

High levels of IgG Anti-IgE Autoantibodies Prevent Early Omalizumab Response in Chronic Spontaneous #Urticaria. Corresponding author: Yoshimichi Okayama

👉doi.org/10.1111/all.16419

#Allergy_journal

20.10.2025 09:48 — 👍 0    🔁 0    💬 0    📌 0

Pascal, M., Chauhan, J., Knol, E., et al. Basophil Activation Test: Bridging Allergy and Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An EAACI Position Paper

🌟One of the most appreciated/liked articles in the social media of Allergy published in 2025:

Basophil Activation Test: Bridging #Allergy and #Oncology for Diagnostic, Therapeutic and Prognostic Applications in AllergoOncology: An #EAACI Position Paper 👉 doi.org/10.1111/all.16607

#Allergy_journal

13.10.2025 09:46 — 👍 0    🔁 1    💬 0    📌 0

Allergy

🌟Allergy — the leading peer-reviewed journal in allergy, asthma & clinical immunology.

🌟Official journal of the EAACI and the most cited publication in its field.

🌟Dedicated to advancing fundamental & applied research worldwide.

🔗 journalallergy.com

#Allergy #Asthma #EAACI #Immunology #Research

09.10.2025 11:06 — 👍 1    🔁 0    💬 0    📌 0